518990-05-1 Usage
General Description
3-HydroxyMethyl-6-Methoxy-1H-indazole is a chemical compound with the molecular formula C9H10N2O2. It is a derivative of indazole, which is a heterocyclic aromatic organic compound. This chemical is a small molecule that has been studied for its potential applications in pharmaceuticals and as a building block in organic synthesis. It is known for its hydroxymethyl and methoxy group substitutions on the indazole ring, which can impart specific chemical and biological properties to the compound. 3-HydroxyMethyl-6-Methoxy-1H-indazole may have potential uses in medicinal chemistry and drug development due to its structural features and potential pharmacological properties. Further research may uncover its potential applications in various fields, including pharmaceuticals, agrochemicals, and materials science. Overall, this compound is of interest to chemists and researchers looking to explore new molecules and their potential applications.
Check Digit Verification of cas no
The CAS Registry Mumber 518990-05-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,1,8,9,9 and 0 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 518990-05:
(8*5)+(7*1)+(6*8)+(5*9)+(4*9)+(3*0)+(2*0)+(1*5)=181
181 % 10 = 1
So 518990-05-1 is a valid CAS Registry Number.
518990-05-1Relevant articles and documents
Scaffold-hopping strategy: Synthesis and biological evaluation of 5,6-fused bicyclic heteroaromatics to identify orally bioavailable anticancer agents
Tung, Yen-Shih,Coumar, Mohane Selvaraj,Wu, Yu-Shan,Shiao, Hui-Yi,Chang, Jang-Yang,Liou, Jing-Ping,Shukla, Paritosh,Chang, Chun-Wei,Chang, Chi-Yen,Kuo, Ching-Chuan,Yeh, Teng-Kuang,Lin, Chin-Yu,Wu, Jian-Sung,Wu, Su-Ying,Liao, Chun-Chen,Hsieh, Hsing-Pang
supporting information; experimental part, p. 3076 - 3080 (2011/06/25)
Utilizing scaffold-hopping drug-design strategy, we sought to identify a backup drug candidate for BPR0L075 (1), an indole-based anticancer agent. For this purpose, 5,6-fused bicyclic heteroaromatic scaffolds were designed and synthesized through shufflin
